Charlie Goodwin | President and CEO |
Tara Semb | CFO |
Matt Hewitt | Craig-Hallum Capital Group |
Kyle Bauser | Dougherty & Company |
Russell Cleveland | RENN Capital Group |
Jeffrey Bernstein | Cowen Prime Advisors |
Good afternoon, ladies and gentlemen, and welcome to the second quarter of fiscal year 2019 earnings conference call for Apyx Medical Corporation. [Operator Instructions]. Please note that this conference call is being recorded and that the recording will be available on the Company's website for replay shortly.
Before we begin, I would like to remind everyone that our remarks and responses to your questions today may contain forward-looking statements that are based on the current expectations of management and involve inherent risks and uncertainties that could cause actual results to differ materially from those indicated, including those identified in the risk factors section of our most recent annual report on Form 10-K filed with the Securities and Exchange Commission, as well as our most recent 10-Q filing.
Such factors may be updated from time to time in our filings with the SEC, which are available on our website.